SCOPUS 정보 검색 플랫폼

Volumn 56, Issue 1, 2001, Pages 118-120

PCV chemotherapy for recurrent glioblastoma mutiforme

(9) Kappelle, A C a Postma, T J a,e Taphoorn, M J B b Groeneveld, G J b Van den Bent, M J a,c Van Groeningen, C J a Zonnenberg, B A b Sneeuw, K C A d Heimans, J J a

a VU UNIVERSITY MEDICAL CENTER (Netherlands)

b UNIVERSITY MEDICAL CENTER UTRECHT (Netherlands)

c ERASMUS MEDICAL CENTER (Netherlands)

d Integraal Kankercentrum Amsterdam (Netherlands)

e VU UNIVERSITY AMSTERDAM (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD TOXICITY; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TUMOR RECURRENCE; VOMITING;

EID: 0035830431 PISSN: 00283878 EISSN: None Source Type: Journal
DOI: 10.1212/WNL.56.1.118 Document Type: Article

Times cited : (90)

References (10)

1
- 0028150911
- Survival of patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
- (1994) Eur J Cancer , vol.30 A , pp. 1808-1815
- Rajan, B.¹ Ross, G.² Lim, C.C.³

2
- 0032767387
- Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
- (1999) J Clin Oncol , vol.17 , pp. 2572-2578
- Wong, E.T.¹ Hess, K.R.² Gleason, M.J.³

3
- 0016799866
- Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors
- (1975) Cancer , vol.35 , pp. 1398-1404
- Gutin, P.H.¹ Wilson, C.B.² Kumar, A.R.V.³

4
- 0018859770
- Modified procarbazine, CCNU and vincristine (PCV) combination chemotherapy in the treatment of malignant brain tumors
- (1980) Cancer Treat Rep , vol.64 , pp. 237-241
- Levin, V.A.¹ Edwards, M.S.² Wright, D.C.³

5
- 0027972896
- Chemotherapy for anaplastic oligodendroglioma
- (1994) J Clin Oncol , vol.12 , pp. 2013-2021
- Cairncross, G.¹ Macdonald, D.² Ludwin, S.³

6
- 0025281789
- Response criteria for phase II studies of supratentorial malignant glioma
- (1990) J Clin Oncol , vol.8 , pp. 1277-1280
- Macdonald, D.R.¹ Cascino, T.L.² Schold S.C., Jr.³ Cairncross, J.G.⁴

7
- 0000414874
- Randomized trial of temodal versus procarbazine in glioblastoma multiforme at first relapse
- Abstract
- (1998) J Neurooncol , vol.39 , pp. 102
- Yung, A.¹ Levin, V.² Albright, R.³

8
- 0022003270
- Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas
- (1985) J Neurosurg , vol.63 , pp. 218-223
- Levin, V.A.¹ Wara, W.M.² Davis, R.L.³

9
- 0031713125
- Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU and vincristine chemotherapy
- (1998) Neurology , vol.51 , pp. 1140-1145
- Van den Bent, M.J.¹ Kros, J.M.² Heimans, J.J.³

10
- 0031885014
- Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma
- (1998) J Neurooncol , vol.38 , pp. 69-75
- Postma, T.J.¹ Van Groeningen, C.J.² Witjes, R.J.G.M.³ Weerts, J.G.E.⁴ Kralendonk, J.H.⁵ Heimans, J.J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.